EVALUATION OF EFFICACY OF INTERLEUKIN 6 AS A MARKER TO DETERMINE THE SEVERITY OF PULP status

Evaluation of efficacy of interleukin 6 as a diagnostic marker to determine the severity of pulpal inflammation - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092224

Enrollment

Registered

2025-08-01

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K029- Dental caries, unspecified

Interventions

Intervention1: interleukin 6 levels variability: Evaluation of efficacy of interleukin 6 as a diagnostic marker to determine the severity of pulpal inflammation for reversible and irreversible pulpiti

Eligibility

Inclusion criteria

Inclusion criteria: Children with dental caries, aged between 6 14 years, with no underlying systemic diseases were included

Exclusion criteria

Exclusion criteria: Recent febrile illness, systemic conditions, and un-cooperative behavior were excluded from the study

Design outcomes

Primary

Measure	Time frame
DIFFERENTIATE BETWEEN REVERSIBLE AND IRREVERSIBLE PULPITIS interms of interleukin 6 levelsTimepoint: 4 weeks	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactMATTA NAVYA

anil neerukonda institute of dental sciences

fauchard2612@gmail.com9493120291

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026